Company Description
SunLink Health Systems, Inc., through its subsidiaries, provides healthcare products and services in the southeastern United States.
The company operates through Healthcare Services and Pharmacy segments. It is also involved in provision of specialty and non-specialty pharmaceutical and biological products, such as nursing homes, assisted living facilities, behavioural and specialty hospitals, hospices, and correctional facilities; non-institutional pharmacy services, including private residences; and durable medical equipment products and services, including the sale and rental of products for institutional clients or to patients in institutional settings and patient-administered home care, as well as retails pharmacy products and services.
In addition, the company owns 3.73 acres of unimproved land; and offers IT services. SunLink Health Systems, Inc. was incorporated in 1959 and is based in Atlanta, Georgia.
| Country | United States |
| Founded | 1959 |
| Industry | Pharmaceutical Retailers |
| Sector | Healthcare |
| Employees | 1,376 |
| CEO | Robert Thornton |
Contact Details
Address: 900 Circle 75 Parkway, Suite 690 Atlanta, Georgia 30339 United States | |
| Phone | 770 933 7000 |
| Website | sunlinkhealth.com |
Stock Details
| Ticker Symbol | SSY |
| Exchange | NYSEAMERICAN |
| Fiscal Year | July - June |
| Reporting Currency | USD |
| CIK Code | 0000096793 |
| CUSIP Number | 86737U102 |
| ISIN Number | US86737U1025 |
| Employer ID | 31-0621189 |
| SIC Code | 8062 |
Key Executives
| Name | Position |
|---|---|
| Robert M. Thornton Jr. | Executive Chairman, Chief Executive Officer and President |
| Mark J. Stockslager | Chief Financial Officer, Principal Accounting Officer and Director |
| Sheila G. Brockman | Vice President |
| Byron D. Finn CPA | President of SunLink ScriptsRX, LLC and Carmichaels Cashway Pharmacy Inc |
| James J. Mulligan | General Counsel and Director Emeritus |
| Theresa Mota | Secretary |
| Neal Miller | President of SunLink HealthCare Technology, Inc |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Nov 12, 2024 | 10-Q | Quarterly Report |
| Oct 25, 2024 | 10-K/A | [Amend] Annual report |
| Oct 18, 2024 | 8-K | Current Report |
| Sep 30, 2024 | 10-K | Annual Report |
| Jul 24, 2024 | 8-K | Current Report |
| Jul 12, 2024 | 8-K | Current Report |
| Jun 7, 2024 | ARS | Filing |
| Jun 6, 2024 | DEF 14A | Other definitive proxy statements |
| Jun 5, 2024 | 8-K | Current Report |
| May 23, 2024 | 8-K/A | [Amend] Current report |